Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
59.92
+0.37 (0.62%)
At close: Jun 6, 2025, 4:00 PM
59.47
-0.45 (-0.75%)
After-hours: Jun 6, 2025, 7:07 PM EDT

Globus Medical Stock Forecast

Stock Price Forecast

According to 10 professional analysts, the 12-month price target for Globus Medical stock ranges from a low of $68 to a high of $115. The average analyst price target of $94.3 forecasts a 57.38% increase in the stock price over the next year.

Price Target: $94.30 (+57.38%)
Analyst Consensus: Buy
Target Low Average Median High
Price $68 $94.3 $97 $115
Change +13.48% +57.38% +61.88% +91.92%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 654443
Buy 555555
Hold 234445
Sell 100000
Strong Sell 000000
Total 141313131313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JMP Securities
JMP Securities
Hold
Reiterates
n/a
Hold Reiterates n/a n/a May 27, 2025
BTIG
BTIG
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 27, 2025
Truist Securities
Truist Securities
Hold
Maintains
$80$68
Hold Maintains $80$68 +13.48% May 12, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$100$80
Buy Maintains $100$80 +33.51% May 9, 2025
Truist Securities
Truist Securities
Hold
Maintains
$82$80
Hold Maintains $82$80 +33.51% Apr 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.91B
from 2.52B
Increased by 15.43%
Revenue Next Year
3.17B
from 2.91B
Increased by 9.01%
EPS This Year
3.33
from 0.75
Increased by 344.52%
EPS Next Year
3.79
from 3.33
Increased by 13.65%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
789.04M958.10M1.02B1.57B2.52B2.91B3.17B3.39B
Revenue Growth
0.47%21.43%6.76%53.35%60.62%15.43%9.01%6.85%
EPS
1.011.441.851.070.753.333.794.27
EPS Growth
-33.55%42.57%28.47%-42.16%-29.91%344.52%13.65%12.64%
Forward PE
-----17.9715.8114.04
No. Analysts
-----171712
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 3.0B 3.4B 3.6B
Avg 2.9B 3.2B 3.4B
Low 2.7B 2.9B 3.1B

Revenue Growth

Revenue Growth 20252026202720282029
High
20.8%
16.6%
14.2%
Avg
15.4%
9.0%
6.8%
Low
8.6%
1.0%
-1.7%

EPS Forecast

EPS 20252026202720282029
High 3.67 4.23 4.70
Avg 3.33 3.79 4.27
Low 2.97 3.24 3.68

EPS Growth

EPS Growth 20252026202720282029
High
389.7%
26.9%
24.2%
Avg
344.5%
13.6%
12.6%
Low
295.9%
-2.7%
-3.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.